rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

OS Therapies Incorporated

OSTX · NYSE American

Health CareBiotechnologyNot moving yet

OSTX stood above a rising 150-day average in 11 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 19.0% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 3
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
29 (+1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$274K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders29+1 on the quarter
New · exited6 · 5
Reported value$5.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026777,651$1.5M+308,184+65.6%
CM Management, LLCunchanged · filed 13 Aug 2026400,000$760K00.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026301,794$573K+21,749+7.8%
HOWARD FINANCIAL SERVICES, LTD.added · filed 7 Jul 2026248,001$471K+2,565+1.0%
BlackRock, Inc.added · filed 7 Aug 2026242,479$461K+177,707+274.4%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026174,132$331K+57,469+49.3%
STATE STREET CORPadded · filed 7 Aug 2026120,100$228K+28,900+31.7%
MARSHALL WACE, LLPnew · filed 13 Aug 2026100,640$191K+100,640
HighTower Advisors, LLCadded · filed 5 Aug 202685,550$163K+70,350+462.8%
NORTHERN TRUST CORPadded · filed 13 Aug 202670,817$135K+4,763+7.2%
30 Sep 2024 – 30 Jun 2026
61728Sep 24Mar 25Sep 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Avril Suzette McKean-Dieser Company insiderDirector · last 22 Jan 20260 · 0
Christopher P. Acevedo Company insiderChief Financial Officer · last 22 Jan 20260 · 0
John Ciccio Company insiderDirector · last 22 Jan 20260 · 0
Karim Galzahr Company insiderDirector · last 22 Jan 20260 · 0
Olivier Roger Jarry Company insiderDirector · last 22 Jan 20260 · 0
Paul A. Romness Company insiderPresident and CEO · last 22 Jan 20260 · 0
Robert Petit Company insiderOfficer · last 22 Jan 20260 · 0
Theodore F. Search Company insiderDirector · last 22 Jan 20260 · 0
Shalom Auerbach Company insider10% owner · last 7 May 20250 · 4
Einodmil Llc Company insider10% owner · last 27 Feb 20250 · 1
Colin Goddard Company insiderDirector · last 5 Dec 20240 · 0

Same industry

MRNA ModernaLeading+147%
IOVA Iovance BiotherapeuticsLeading+126%
ABCL AbCellera BiologicsLeading+60%
HALO Halozyme TherapeuticsLeading+46%
XERS Xeris Biopharma HoldingsLeading+38%
ENTX Entera BioLeading+37%
HELP Helus PharmaLeading+36%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 26 Mar 20266.5%
Cash and equivalentsFY 2025 · to 31 Dec 2025$270K
Free cash flowFY 2025 · to 31 Dec 2025−$14.7M

Analyst forecasts

No analyst forecasts yet.